Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of bevacizumab plus chemotherapy in previously untreated metastatic breast cancer
2006-000378-61Phase 3Completed
- Sponsor
- Genentech
- Start
- Apr 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Bevacizumab plus chemotherapy with Placebo plus chemotherapy (2 arms). Primary endpoint: Progression-free survival. Started Apr 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-000378-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000378-61.